financetom
Business
financetom
/
Business
/
Warner Bros. Discovery's Planned Split to Set The Stage for Additional Industry Consolidation, UBS Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Warner Bros. Discovery's Planned Split to Set The Stage for Additional Industry Consolidation, UBS Says
Jun 10, 2025 12:25 PM

03:13 PM EDT, 06/10/2025 (MT Newswires) -- Warner Bros. Discovery's ( WBD ) recently announced split will present new opportunities to "confront secular headwinds" in linear TV and avenues to drive greater scale in direct-to-consumer, UBS said in a note emailed Tuesday.

Warner Bros. on Monday said it intends to separate into two publicly traded media companies by mid-2026.

The company will split its business into Streaming & Studios and Global Networks, with the latter retaining up to a 20% share in Streaming & Studios that is expected to be monetized to reduce debt.

According to UBS, the transaction could set the stage for additional industry consolidation and present new synergy opportunities.

Meanwhile, the firm estimated the S&S business could generate $2.9 billion of earnings before interest, taxes, depreciation, and amortization in 2025, growing to $3.3 billion in 2026, assuming a 50/50 split of corporate overhead.

"We believe the return to the HBO brand should lead to a more focused content strategy/budget," the firm said.

For GN, the firm said it was estimating $6 billion in EBITDA for 2025, which would decline to $5.3 billion in 2026 with a focus on cash generation and debt paydown.

"While the transaction could better highlight underlying asset value, we await improved visibility on the ramp in studio/streaming EBITDA and expect secular challenges for entertainment based linear TV assets to continue," the firm wrote.

UBS has a neutral rating on the stock with a $9 price target.

Price: 10.06, Change: +0.53, Percent Change: +5.51

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Iris Energy Mines 230 Bitcoin in May; Shares Rise
Iris Energy Mines 230 Bitcoin in May; Shares Rise
Jun 6, 2024
12:48 PM EDT, 06/06/2024 (MT Newswires) -- Iris Energy ( IREN ) said Thursday it mined 230 bitcoins in May, down from 358 in April. The company said the decrease in bitcoin mined in May was due to reduced block subsidy, partially offset by a 14% increase in average operating hashrate. Based on its 2024 expansion schedule, the firm plans...
Bitcoin Mining Stock Iris Energy Is Trading Higher: What's Going On?
Bitcoin Mining Stock Iris Energy Is Trading Higher: What's Going On?
Jun 6, 2024
Iris Energy Ltd ( IREN ) stock is trading higher. The company on Thursday issued its monthly operations update. The Details: Iris Energy ( IREN ) announced that it mined 230 Bitcoin (CRYPTO: BTC) in May, down from 358 in April and 353 in March. The lower mining total was due to reduced block subsidy following April’s halving event. Iris...
Canadian National Railway Formally Offers Binding Arbitration to the Teamsters Canada Rail Conference
Canadian National Railway Formally Offers Binding Arbitration to the Teamsters Canada Rail Conference
Jun 6, 2024
12:42 PM EDT, 06/06/2024 (MT Newswires) -- Canadian National Railway ( CNI ) Thursday said it formally offered the Teamsters Canada Rail Conference (TCRC) to enter into binding arbitration earlier this week. This process has a mutually agreed upon independent arbitrator settle the labor dispute by evaluating the demands of each side and deciding on the terms of the new...
Update: Halozyme Therapeutics Lifts 2024 Guidance -- Shares Surge
Update: Halozyme Therapeutics Lifts 2024 Guidance -- Shares Surge
Jun 6, 2024
12:34 PM EDT, 06/06/2024 (MT Newswires) -- (Updates with share price movement in the headline and first paragraph.) Halozyme Therapeutics ( HALO ) shares were up 13% in recent trading Thursday after the company said it is raising its 2024 guidance after receiving a European patent for its Enhanze drug delivery technology. The company said it now expects 2024 non-GAAP...
Copyright 2023-2026 - www.financetom.com All Rights Reserved